Rubens Sievert is an Endocrinology/Metabolic physician affiliated with Broward Health. OpenAlex indexes 6 publications with 497 citations (h-index 3).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4800 W Hillsboro Blvd.
Suite A-6
Coconut Creek, FL 330734371
Telephone
954-481-9184Registry record last updated 9 Feb 2018.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- KCI USA, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
49.7%GLP-1 receptor agonist14%Ozempic51%Trulicity24%Mounjaro15%Rybelsus10%Part D<11 patientsInsulin Analog12.2%Novolog Flexpen32%Tresiba Flextouch U-20024%Novolog17%Lantus Solostar12%Lantus9%Tresiba Flextouch U-1006%Part D<11 patients+ 8 more classes in this area
Hormonal (systemic)
26.4%l-Thyroxine21%Levothyroxine Sodium88%Synthroid12%Part D≥110 patientsThyroid Hormone Synthesis Inhibitor4.4%Methimazole100%Part D≥25 patients+ 1 more class in this area
Cardiovascular
17.5%Statin9.8%Rosuvastatin Calcium60%Atorvastatin Calcium35%Simvastatin6%Part D<11 patientsAngiotensin receptor blocker (ARB)1.9%Losartan Potassium66%Losartan-Hydrochlorothiazide34%Part D<11 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Abstract C068: Primary adrenocortical insufficiency as a presenting symptom of acute myeloid leukemia
Cancer Epidemiology Biomarkers & Prevention
2024 - Minimal Cardiac Effects in Asymptomatic Athyreotic Patients Chronically Treated with Thyrotropin-suppressive Doses of L-Thyroxine—Authors’ Response
The Journal of Clinical Endocrinology & Metabolism
1998 - Minimal Cardiac Effects in Asymptomatic Athyreotic Patients Chronically Treated with Thyrotropin-Suppressive Doses of<scp>l</scp>-Thyroxine<sup>1</sup>
The Journal of Clinical Endocrinology & Metabolism
1997
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”